Congress Funded the Science. OMB Put It in a Desk Drawer.

The newsroom coffee tastes like burnt circuitry and regret. My phone buzzes with the pre-hearing kind of static, the sound you get right before somebody decides to lie into a microphone. Out in the real world, lab freezers keep humming, postdocs keep refreshing inboxes, and a grant pipeline that is supposed to be boring has been turned into political theater.

Boring is good. Boring is predictable. Boring is how you plan experiments that take longer than a cable segment.

OMB slows release of Congress-approved science funding

Nature reports that weeks after Congress rejected the Trump administration’s proposed cuts to science, the White House Office of Management and Budget (OMB) has been slow to authorize the release of money Congress already approved and the President signed into law on February 3, 2026. Nature says the NIH had not received approval to spend any of that research funding. The NSF got authorization only last week. NASA got authorization too, but with an unusual restriction: OMB told NASA it could not spend new money on ten specific science programs until the agency provides more detail. OMB did not answer Nature’s questions about why the money is being held up or when it will be cleared.

This is where the grown-ups usually whisper: budgeting is complicated.

So is surgery. That does not mean you yank the lights out mid-operation and call it “process.”

Translation: not oversight, leverage

Translation: Congress appropriates money. Agencies run programs. OMB’s apportionment process is supposed to be plumbing, not a valve you crank shut to force obedience. If NIH cannot spend funds signed into law on February 3, that is not a paperwork hiccup. That is a decision.

Here is the mechanism: grant cycles are timed. Peer review is timed. Hiring is timed. Animal protocols and clinical research are timed. When you choke the flow at the top, the system downstream becomes improvisation. People stop starting projects. People stop recruiting. People stop taking risks, because the incentive structure got booby-trapped.

Nature also notes the damage in numbers. Delays, plus the record 43-day government shutdown in October to November, mean NIH awarded only about 30% as many new research grants this fiscal year as it had by this time in each of the past six years. NSF was at about 20%.

Follow the money: who wins when public science stalls

Follow the money: when public research stalls, private power gets to set the menu. NIH and NSF fund work that does not have to answer to shareholders. Slow-walking apportionment tilts the field toward whoever can keep moving while universities freeze.

Nature adds that NASA’s footnote put ten science programs on a leash, including missions to Venus and an Earth-threatening asteroid, plus Earth-science satellites. In plain English: specific scientific work is being treated like it needs political permission.

The quiet part: control the spigot, control the story

The quiet part is narrative control. Delay funds without a vote, and you can punish entire fields without writing a headline that admits what you did. Nature reports OMB Director Russell Vought has called OMB’s funding role an “indispensable statutory tool” to ensure agencies follow White House priorities, and he has argued OMB can provide less funding than Congress appropriates. That is the thesis: Congress writes the law, but the White House writes the reality.

Nature asked OMB for answers. No response. That silence is the point.